Penn State: 'Anti-Antibiotic' Allows for Use of Antibiotics Without Driving Resistance
December 02, 2020
December 02, 2020
UNIVERSITY PARK, Pennsylvania, Dec. 2 (TNSJou) -- Pennsylvania State University issued the following news on Dec. 1:
An inexpensive, FDA-approved drug -- cholestyramine -- taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team's findings appear today (Dec. 1) in the journal eLife.
"Antimicrobial resistance is a serious . . .
An inexpensive, FDA-approved drug -- cholestyramine -- taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team's findings appear today (Dec. 1) in the journal eLife.
"Antimicrobial resistance is a serious . . .